Mylan Loses Bid To Dismiss MS Drug Patent Suit
By Kaitlin Ugolik ( August 29, 2011, 7:17 PM EDT) -- Mylan Pharmaceuticals Inc. lost a bid Monday to dismiss Teva Pharmaceutical Industries Ltd.'s patent suit over the multiple-sclerosis drug Copaxone when a New York federal judge found that the drug's patents are valid....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.